VIM and acute myeloid leukemia: Levels of circ-vimentin (circ-VIM) are positively correlated with the number of white blood cells (WBC), lower overall survival (OS), and leukemia-free survival (LFS) in AML patients, which means circ-VIM can be an ideal biomarker for the progression and prognosis of AML (71) (Table 1).